On April 1, 2026, Instil Bio, Inc. announced the appointment of RSM US LLP as its new independent registered public accounting firm for the fiscal year ending December 31, 2026. This decision was made by the Audit Committee of the Board of Directors and resulted in the dismissal of Deloitte & Touche LLP, effective the same day. The reports from Deloitte on the company's consolidated financial statements for the fiscal years ended December 31, 2025, and 2024 did not contain any adverse opinions or disclaimers. Furthermore, there were no disagreements with Deloitte regarding accounting principles or practices during the audit periods. The company has provided Deloitte with a copy of the disclosures and requested a letter confirming their agreement with the statements made in the filing. This transition in auditors is a routine administrative matter and is not expected to have a significant impact on the company's stock price or operations.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.